Novonesis (Novozymes) B (FRA:NZM2) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Novonesis (Novozymes) B ROE % Adjusted to Book Value?

Novonesis (Novozymes) B's ROE % for the quarter that ended in Jun. 2024 was 0.00%. Novonesis (Novozymes) B's PB Ratio for the quarter that ended in Jun. 2024 was 2.39. Novonesis (Novozymes) B's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 0.00%.

Novonesis (Novozymes) B ROE % Adjusted to Book Value Historical Data

The historical data trend for Novonesis (Novozymes) B's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B ROE % Adjusted to Book Value Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.42

2.86

2.16

4.07

2.94

Novonesis (Novozymes) B Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.14	2.84	4.93	2.69	-

Competitive Comparison of Novonesis (Novozymes) B's ROE % Adjusted to Book Value

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's ROE % Adjusted to Book Value Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's ROE % Adjusted to Book Value falls into.

Novonesis (Novozymes) B ROE % Adjusted to Book Value Calculation

Novonesis (Novozymes) B's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.75%	/	7.39
	=	2.94%

Novonesis (Novozymes) B's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	2.39
	=	0.00%

Novonesis (Novozymes) B ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (FRA:NZM2) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines